Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial
Recruiting · NCT07576660 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sepsis, Systemic Inflammatory Response Syndrome, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Phase 3 | 2026-09-02 | NCT07576660 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Southeast University, China | 36 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongda Hospital, School of Medicine, Southeast University | Nanjing | China | 1 |
| Zhongda Hospital, School of Medicine, Southeast University | Nanjing | China | 9 |